Herpes & HIV/AIDS: Management and Treatment Options

While neither herpes simplex virus (HSV) nor human immunodeficiency virus (HIV) has a cure, effective treatments exist to manage symptoms, suppress viral activity, and reduce transmission risk.

Herpes Simplex Virus (HSV)

Types

• HSV-1: Primarily oral herpes (cold sores).
• HSV-2: Primarily genital herpes.
• Both can infect either site via oral-genital contact.

Antiviral Therapy

• Episodic treatment: Taken at outbreak onset (e.g., acyclovir 400mg 3x/day × 5 days, valacyclovir 1g 2x/day × 1 day, famciclovir 1g 2x/day × 1 day).
• Suppressive therapy: Daily dosing (acyclovir 400mg 2x/day, valacyclovir 500mg-1g daily, famciclovir 250mg 2x/day) reduces outbreak frequency by 70-80% and asymptomatic shedding by ~50%.
• Treatment is lifelong; periodic reassessment needed.

Human Immunodeficiency Virus (HIV)

Antiretroviral Therapy (ART)

• Goal: Suppress viral load to undetectable levels (<200 copies/mL), preserving immune function and preventing progression to AIDS.
• Regimens: Typically 3-drug combinations (2 NRTIs + INSTI/NNRTI/PI). Modern first-line: bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) or dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF).
• U=U: Undetectable = Untransmittable. Sustained viral suppression eliminates sexual transmission risk.
• Adherence is critical: Missed doses risk resistance.

Monitoring & Prevention

• CD4 count & viral load every 3-6 months.
• PrEP (pre-exposure prophylaxis) for HIV-negative partners.
• Regular STI screening, vaccinations (HPV, Hep A/B, pneumococcal).

Shared Principles

• Early diagnosis improves outcomes.
• Stigma reduction enhances care engagement.
• Multidisciplinary care: medical, psychological, social support.
• Open communication with partners about status and prevention.